Provention Bio Appoints Miguel Sanjuan as Senior Vice President of Research and Early Development
November 05, 2021 at 04:30 pm EDT
Provention Bio, Inc. announced the appointment of Miguel Sanjuan, Ph.D. as Senior Vice President of Research and Early Development. Dr. Sanjuan further strengthens the company's internal expertise in the core areas of immunomodulatory therapy, translational medicine and autoimmune disease. Dr. Sanjuan most recently served as vice president, head of translational biology at Gossamer Bio and founder of Gossamer's therapeutic biologics group.